Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
15
NCT04751786
Dose Escalation Study of Immunomodulatory Nanoparticles
Phase: Phase 1
Role: Collaborator
Start: Jan 11, 2021
Completion: Dec 31, 2025